|
⚲
|
| Acetylon Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001469566 |
| Sale | 2009-07-24 ($8.0 M Offered, $7.2 M Sold) |
| Fund | |
| Phone | 6174352664 |
| Address | c/o National Registered Agents, Inc Boston, 02210 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Walter Ogier | |
| James Bradner | |
| Elena Prokupets | |
| Bruce Downey | |
| Kenneth Anderson | |
| Marc Cohen |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Smith Clarence Edward
✚
|
0.0 | |
|
Smith Clark C.
✚
|
0.0 | |
|
Smith Craig Harder
✚
|
0.0 | |
|
Smith Curtis
✚
|
0.0 | |
|
Smith Dacona
✚
|
0.0 | |
|
Smith Darla M
✚
|
0.0 | |
|
Smith David A
✚
|
0.0 | |
|
Smith Devyn
✚
|
0.0 | |
|
Smith Evan Walker
✚
|
0.0 | |
|
Smith Christopher M
✚
|
0.0 |